Prospective study of the prescription of anidulafungin for serious intra-abdominal infections hospitalized in resuscitation

Trial Profile

Prospective study of the prescription of anidulafungin for serious intra-abdominal infections hospitalized in resuscitation

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 23 Jan 2017

At a glance

  • Drugs Anidulafungin (Primary)
  • Indications Candidiasis; Intra-abdominal infections
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 23 Jan 2017 New trial record
    • 14 Jan 2017 Results (n=14) published in the Journal of Antimicrobial Chemotherapy
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top